PWMG
ATOS icon

Prestige Wealth Management Group’s Atossa Therapeutics ATOS Stock Holding History

Prestige Wealth Management Group’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19
Closed – – 975
2022
Q1 		$0 Hold
19
– – ﹤0.01% 980
2021
Q4 		$0 Hold
19
– – ﹤0.01% 995
2021
Q3 		$1K Hold
19
– – ﹤0.01% 858
2021
Q2 		$2K Hold
19
– – ﹤0.01% 767
2021
Q1 		$1K Buy
+19
New +$694 ﹤0.01% 850

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prestige Wealth Management Group's ATOS Position: Q2 2022 in Review

Prestige Wealth Management Group sold out of Atossa Therapeutics (ATOS) in Q2 2022, closing a stake of 19 shares.

Prestige Wealth Management Group first reported a position in ATOS in Q1 2021 and held it in 5 quarters. The position peaked at $2K in Q2 2021. 73 funds tracked by Wall St. Rank hold ATOS as of Q2 2022.

  • Prestige Wealth Management Group reported no remaining Atossa Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Prestige Wealth Management Group sold 19 Atossa Therapeutics shares in Q2 2022.
  • Prestige Wealth Management Group first reported a position in Atossa Therapeutics in Q1 2021 and held it in 5 quarters.
  • Prestige Wealth Management Group's Atossa Therapeutics position peaked at $2K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2022.

Based on Prestige Wealth Management Group's 13F filing for Q2 2022, filed 10 Aug 2022.